Glabellar contraction patterns: A tool to optimize botulinum toxin treatment

Dermatologic Surgery

Volumn 38, Issue 9, 2012, Pages 1506-1515

  De Almeida, Ada R Trindade ^a   Da Costa Marques, Elisa R M ^a   Banegas, Raul ^b   Kadunc, Bogdana V ^a  

^a HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^b Centro Arenales   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

ADULT; ARTICLE; DRUG EFFECT; EYEBROW; FACE; FEMALE; GLABELLA; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL RECORD REVIEW; MUSCLE CONTRACTION; PHOTOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN; WRINKLE;

ADULT; AGED; BOTULINUM TOXINS; FACIAL MUSCLES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; NEUROMUSCULAR AGENTS; PHOTOGRAPHY; RETROSPECTIVE STUDIES; SKIN AGING;

EID: 84866405679     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2012.02505.x     Document Type: Article

References (39)

1. Lewis MB, Bowler PJ,. Botulinum toxin cosmetic therapy correlates with a more positive mood. J Cosmet Dermatol 2009; 8 (1): 24-6.
2. Sommer B, Sattler G, eds Botulinum toxin in aesthetic medicine. Blackwell Science: Berlin, 2001; pp. 30-1.
3. Madeira CL, Marques EM,. Noções de anatomia da face. In:, Gadelha AR, Costa IMC, editors. Cirurgia dermatolõgica em consultõrio. Rio de Janeiro: Atheneu; 2003; pp. 77-94.
4. Hankis CL, Strimling R, Rogers GS,. Botulinum a toxin for glabellar wrinkles. Dose and response. Dermatol Surg 1998; 24 (11): 1181-3. (Pubitemid 28533284)
5. Carruthers A, Carruthers J, Lei X, Pogoda J., OnabotulinumtoxinA treatment of mild glabellar lines in repose. Dermatol Surg 2010; 36: 2168-71.
6. Carruthers J, Fagien S, Matarasso SL, Alster T, et al. Consensus recommendations n the use of botulinum toxin type A in facial aesthetics. Plast Reconstr Surg 2004; 114 (Suppl 6): 1S-22S. (Pubitemid 40354480)
7. Carruthers J, Glogau R, Blitzer A,. Facial aesthetics consensus group faculty advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations. Plast Reconstr Surg 2008; 121 (5): 5S-30S. (Pubitemid 351674120)
8. Draelos ZD,. The shrinking word: skin considerations in a global community. J Cosmet Dermatol 2006; 5 (1): 1-2.
9. Flynn TC,. Botox in men. Dermatol Ther 2007; 20: 407-13. (Pubitemid 350265329)
10. Carruthers A, Carruthers J,. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol Surg 2005; 31 (10): 1297-303. (Pubitemid 41587037)
11. Porter JP, Lee JI,. Facial analysis: maintaining ethnic balance. Facial Plast Surg Clin North Am 2002; 10 (4): 343-9. (Pubitemid 36113442)
12. Ahn KY, Park MY, Park DH, Han DG,. Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans. Plast Reconstr Surg 2000; 105 (2): 778-84.
13. Matarasso S,. Botulinum toxin: concepts and use in 2008. Adv Dermatol 2008; 24: 1-13.
14. Monheit G, Carruthers A, Brandt F, Rand R,. A randomized, double-blinded, placebo-controlled study of botulinum toxin type A for the treatment of glabellar lines: determination of the optimal dose. Dermatol Surg 2007; 33 (suppl 1): S51-9. (Pubitemid 46051400)
15. Rexbeye H, Petersen I, Johansens M, Klitkou L, et al. Influence of environmental factors in facial aging. Age Ageing 2006; 35 (2): 110-5.
16. Rzany B, Ascher B, Fratila A, Monheit G, et al. Efficacy and safety of 3-and 5-injection patterns (30 and 50 U of botulinum toxin A(Dysport) for the treatment of wrinkles in the glabella and the central forehead region. Arch Dermatol 2006; 142 (3): 320-6.
17. Carruthers A, Carruthers J,. Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin. Dermatol Surg 1998; 24 (11): 1189-94. (Pubitemid 28533286)
18. Carruthers J, Carruthers A,. Botulinum toxin type A treatment of multiple upper facial sites: patient-reported outcomes. Dermatol Surg 2007; 33 (1 Spec No): S10-7. (Pubitemid 46051394)
19. Fagien S, Cox SE, Finn JC, Werschler WP, et al. Patient-reported outcomes with botulinum toxin type A treatment of glabellar rhytides: a double-blind, randomized placebo-controlled study. Dermatol Surg 2007; 33 (1 Spec No): S2-9. (Pubitemid 46051393)
20. Levy JL, Pons F, Jouve E,. Management of the ageing eyebrow and forehead: an Objective dose-response study with botulinum toxin. J Eur Acad Dermatol Venereol 2006; 20 (6): 711-6.
21. Tiryaki T, Ciloglu S,. Eyebrow asymmetry: definition and symmetrical correction using botulinum toxin A. Aesthetic Surg J 2007; 27: 513-7. (Pubitemid 47491625)
22. Lehrer M, Benedetto A,. Botulinum toxin- an update on its use in facial rejuvenation. J Cosmet Dermatol 2005; 4: 285-97.
23. Carruthers A, Carruthers J,. Eyebrow height after botulinum toxin type A to the glabella. Dermatol Surg 2007; 33 (1): S26-31. (Pubitemid 46051396)
24. Bassichis B,. Cosmetic use of botulinum toxin in the upper face. Oper Tech Otolaryngol 2007; 18: 248-53. (Pubitemid 350121161)
25. Klein A,. Complications, adverse reactions and insights with the use of botulinum toxins. Dermatol Surg 2003; 29 (5): 549-56. (Pubitemid 36583157)
26. Klein A,. Contraindications and complications with the use of botulinum toxins. Clin Dermatol 2004; 22: 66-75. (Pubitemid 38670107)
27. Fagien S, Raspaldo H,. Facial rejuvenation with botulinum neurotoxin: an anatomical and experiential perspective. J Cosmet and Laser Ther 2007; 9 (Suppl 1): 23-31. (Pubitemid 47450878)
28. Trindade de Almeida AR, Marques ER, Kadunc BV,. Glabellar wrinkles: a pilot study of contraction patterns. Surg Cosmet Dermatol 2010; 2 (1): 23-8.
29. Petrus GM, Lewis D, Maas CS,. Anatomic considerations for treatment with botulinum toxin. Facial Plast Surg Clin North Am 2007; 15 (1): 1-9.
30. Macdonald MR, Spiegel JH, Raven R, Kabaker S, et al. An anatomical approach to glabellar rhytids. Arch Otolaryngol Head Neck Surg 1998; 124: 1315-20. (Pubitemid 28564105)
31. De Maio M,. Mímica facial. In:, De Maio M, editor. Tratado de medicina estética. vol. 75. São Paulo: Roca; 2004. pp. 1321-5.
32. Knize DM,. Muscles that act on glabellar skin: a closer look. Plast Reconstr Surg 2000; 105 (1): 350-61. (Pubitemid 30027073)
33. Finn JC, Cox SE,. Practical botulinum toxin anatomy. In:, Carruthers A, Carruthers J,. editors. Botulinum toxin. vol. 3. Philadelphia, PA: Elsevier Saunders; 2005. pp. 19-30.
34. Rubin LR,. The anatomy of a smile: its importance in treatment of facial paralysis. Plast Reconstr Surg 1974; 53 (4): 384-7.
35. Kane MC,. The effect of botulinum toxin injections on the nasolabial fold. Plast Reconstr Surg 2003; 112 (5 Suppl): 66S-72S.
36. Kane MC,. Classification of crow's feet patterns among caucasian women: the key to individualizing treatment. Plast Reconstr Surg 2003; 112 (5 Suppl): 33S-9S.
37. Tamura B, Odo M, Chang B, Cucé L., et al. Treatment of nasal wrinkles with botulinum toxin. Dermatol Surg 2005; 31 (3): 271-5. (Pubitemid 43072977)
38. Braz AV, Sakuma TH,. Patterns of contraction of the frontalis muscle. Surg Cosm Dermatol 2010; 2 (3): 191-4.
39. Kaminer MS, Hruza GJ,. Botulinum A exotoxin injections for photoaging and hyperhidrosis. In:, Kaminer MS, Dover JS, Arndt KA, editors. Atlas of cosmetic surgery, (1st ed). Philadelphia, PA: Saunders; 2002. pp. 292-309.